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 59 
Thesis Abstract 60 
 61 
Pathogen spillover to novel hosts represents a huge selective event, and can 62 
result in rapid evolutionary changes in both the pathogen and the host. 63 
However, it is seldom possible to identify which specific host characteristics 64 
are under selection following emergence, nor understand the evolutionary 65 
repercussions of these changes. In the early 1990’s, Mycoplasma 66 
gallisepticum emerged in North American house finches (Haemorhous 67 
mexicanus) following a jump from poultry. Previous studies monitoring 68 
disease spread and response to infection provided details of temporal and 69 
geographic patterns of host history of exposure, including evidence of the 70 
evolution of resistance in populations with a long history of exposure. In this 71 
thesis, I explore the specific host responses that were subject to selection 72 
following disease emergence in coevolved, relative to unexposed populations 73 
and evaluate how this led to the qualitative disease dynamics previously 74 
observed. In chapter one, I show that susceptibility to infection must be equal 75 
in both susceptible and resistant host genotypes in order for selection to 76 
occur, with mortality avoidance most likely driving the mode and tempo of 77 
rapid selection on resistance and virulence evolution observed in this system. 78 
In the second chapter, I find limited evidence for a protective benefit of a 79 
commonly measured immune component: systemic antibody, and show other 80 
important immune processes that are involved in host resistance, including an 81 
avoidance of immune manipulation. Findings presented here demonstrate the 82 
importance of the specific mechanism of host responses in determining 83 
evolutionary trajectories.  84 
	 4	
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Chapter 1: General Introduction 194 
 195 
 196 
Infectious diseases are important selective agents in a range of species, 197 
including humans (Karlsson et al., 2014), and have had devastating effects on 198 
biodiversity due to their contribution to recent species declines (Lips et al., 199 
2006; Pounds et al., 2006). Interpreting the protective benefits of host 200 
responses to infection is complex, particularly in scenarios where pathogens 201 
are able to manipulate host responses and cause damage through 202 
immunopathology. Furthermore, external or unrelated ecological factors 203 
including, but not limited to: host condition (Cornet et al., 2014), resource 204 
availability (Pedersen & Greives, 2008) and climate (Atkinson et al., 2014) can 205 
all influence the strength and type of response elicited, due to physiological 206 
and energetic trade offs with other biological processes (Hawley et al., 2012; 207 
Cheatsazan et al., 2013).  208 
 209 
An additional layer of complexity facing ecologists and evolutionary biologists 210 
is that hosts and pathogens continually adapt to one another, on both spatial 211 
and temporal scales (Lively & Dybdahl, 2000; Decaestecker et al., 2007) and 212 
therefore the immune response is a dynamic and responsive process. As all 213 
organisms including humans, live in a constantly varying environment, it is 214 
therefore important that we aim to understand as much as possible about the 215 
ecological interactions of hosts and pathogens in the context of natural 216 
populations (Pedersen & Babayan, 2011).  217 
 218 
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There is growing appreciation that understanding host defenses at the 219 
immediate time of infection is crucial for understanding the evolutionary 220 
trajectories of host resistance and pathogen evolution (Mackinnon & Read, 221 
2004). This knowledge is useful not only in developing treatments (Gandon et 222 
al., 2001), but also for targeting strategies for preventative measures (Griffin & 223 
Catlla, 2013). Specifically, the nature of host responses can have a direct 224 
impacts on pathogen evolution, influencing strategies for both transmission 225 
and the level of damage they cause (Gandon & Michalakis, 2000; de Roode 226 
et al., 2008). For example, theoretical models have suggested that different 227 
host strategies including pathogen growth inhibition, infection avoidance, or 228 
tolerance, can affect whether pathogens evolve increasing, or decreasing 229 
virulence (Gandon & Michalakis, 2000; Restif & Koella, 2003; Miller et al., 230 
2005, 2006).  231 
 232 
The overarching aim of this thesis is to explore how different host defense 233 
strategies influence host and pathogen evolution in North American house 234 
finches (Heamorhous mexicanus), and the bacterial pathogen Mycoplasma 235 
gallisepticum. The research herein utilizes a variety of techniques including 236 
mathematical modeling to generate hypotheses about the underlying 237 
evolutionary mechanisms and infection dynamics in this system, as well as 238 
analysis of the protective benefits of immune measures using transcriptomics 239 
and molecular methods. The consistent underlying feature throughout is the 240 
comparison of two host populations; Eastern finches from Alabama who have 241 
been exposed to M.gallisepticum for over 20 years, versus Western finches 242 
	 9	
from Tempe, Arizona, who have remained naïve to the disease (Staley et al. 243 
2017, in press). 244 
 245 
The emergence of M.gallisepticum in North American house finches 246 
M.gallisepticum is a common pathogen of poultry (Avakiana & Leyb, 1993; 247 
Gaunson et al., 2000a). In 1994, a novel strain emerged in North American 248 
house finches, first reported in Washington DC (Ley et al., 1996; Fischer et 249 
al., 1997), before spreading rapidly in the Eastern and Northern range of the 250 
species (Dhondt et al., 2005). Infection in the house finch results in severe 251 
conjunctivitis and a disease of the upper respiratory tract (Ley et al., 1996), 252 
resulting in extremely high mortality rates (Hochachka & Dhondt, 2000). In an 253 
effort to monitor disease spread, André Dhondt and colleagues set up the 254 
volunteer-based monitoring scheme, the House Finch Disease Survey 255 
(HFDS) (Dhondt et al., 2006).  256 
 257 
By the early 2000s, M.gallisepticum had moved Westwards, first appearing in 258 
those from Missoula, MT (Duckworth et al., 2003) and later in Portland, OR 259 
(Ley et al., 2006). Western populations are native to the U.S, differing 260 
genetically to Eastern populations with little known admixture (Hawley et al., 261 
2008). However the low density of Western house finches across the Great 262 
Plains, coupled with the non-migratory behaviour of the Western populations 263 
(Sauer et al., 2012) meant that disease spread more slowly in these regions. 264 
Once established in different populations, it began to vary seasonally in 265 
prevalence on both local and regional scales (Hartup et al., 1998; Altizer et 266 
al., 2004; Dhondt et al., 2005) characterised by semi-annual peaks, 267 
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corresponding to seasonal host aggregation and breeding (Hosseini et al., 268 
2004).  269 
 270 
Pathology and immune responses to M.gallisepticum 271 
As aforementioned, M.gallisepticum manifests itself as a severe conjunctivitis, 272 
characterised by conjunctival edema and disease of the upper respiratory 273 
tract (Kollias et al., 2004). Other symptoms of infection include decreased 274 
motor activity (Kollias et al., 2004), mass loss (Bonneaud et al., 2012a) and 275 
an increase in body temperature (Hawley et al., 2012). In experimental 276 
infection studies, morbidity was high (100%;(Kollias et al., 2004)), but 277 
mortality varied from just 5% (Kollias et al., 2004) to over 90% (Farmer et al., 278 
2002).  279 
 280 
As M.gallisepticum is an economically important disease affecting poultry 281 
(Stipkovits & Kempf, 1996), much of what we know about its pathogenicity 282 
and the immune processes involved with infection are from experimental 283 
infections of both virulent and attenuated strains of poultry MG in chickens 284 
(Mohammed et al., 2007). MG has the ability to misdirect some components 285 
of the inflammatory response, such that epithelial membranes on respiratory 286 
mucosa are disrupted, allowing increased adherence and multiplication in 287 
these tissues (Gaunson et al., 2006). The ability of Mycoplasmas to both 288 
suppress and potentiate different aspects of host immunity makes it 289 
challenging to determine which processes that are under host versus 290 
pathogen control (Staley & Bonneaud, 2015).  291 
 292 
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One approach to teasing apart host versus pathogen control of immune 293 
processes in house finches is to make use of the comparison between 294 
unexposed Western and exposed Eastern populations. In an experimental 295 
infection of finches from both populations in 2007, Bonneaud and colleagues 296 
found that birds from exposed (Alabama) populations up-regulated genes 297 
associated with immunity, relative to finches from unexposed populations 298 
(Arizona) (Bonneaud et al., 2011). Furthermore, birds from unexposed 299 
populations down-regulated immune genes at two weeks post infection, 300 
suggesting that unexposed birds were more susceptible to 301 
immunosuppression, consistent with the evolution of resistance in Eastern 302 
birds (Wang et al., 2006; Bonneaud et al., 2011).  303 
 304 
In a later study, it was revealed that significant differences in splenic gene 305 
expression between populations as early as 3dpi could be detected, indicating 306 
that the spread of resistance involved a change in innate immune processes 307 
(Bonneaud et al., 2012b). Unexposed birds down-regulated genes associated 308 
with immunity at 14dpi, but up-regulated complement-factor H gene, which is 309 
known to constrain the activity of the complement cascade. However, 310 
exposed birds were able to up-regulate genes involved with protective 311 
immunity, such as CD74, which is associated with the assembly of MHC class 312 
II associated molecules. Thus, it was concluded that gene expression patterns 313 
were consistent with the hypothesis that some components of the immune 314 
response were being suppressed in finches from Western populations, and 315 
that birds from Eastern populations had enhanced protective immunity by 316 
comparison (Bonneaud et al., 2012b).  However, in spite of an awareness of 317 
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some of the components of the house finch immune response to MG, their 318 
protective benefits, as well as the conditions leading to rapid selection on host 319 
resistance traits, remains to be elucidated.  320 
 321 
 322 
Thesis overview  323 
All of the work herein focuses on the exposed and unexposed populations 324 
described above, aiming to examine the conditions that allowed for rapid host 325 
evolution, and the functional significance of inter-population differences in 326 
host immune response. Each chapter is written as a discrete manuscript, with 327 
an abstract, introduction, methods, results and discussion.  328 
  329 
Chapter 2: Quantitative host resistance drives the evolution of increased 330 
virulence in an emerging pathogen 331 
Emergent infectious diseases can have a devastating impact on host 332 
populations and generate high selective pressures on both hosts and 333 
pathogens. As a consequence, rapid adaptations in host resistance and 334 
pathogen virulence are frequently observed following an initial severe 335 
outbreak. However, it is often unclear to what extent hosts will evolve to 336 
prevent infection (qualitative resistance) or limit its deleterious effects 337 
(quantitative resistance) and what the evolutionary repercussions will be for 338 
the pathogen. Previous studies on MG in house finches have indicated that 339 
the evolution of host resistance occurred rapidly, within just a few generations 340 
(Bonneaud et al., 2011), accompanied by parallel patterns of increased 341 
pathogen virulence (Hawley et al., 2013). Using a two strain, two host SIR-342 
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based evolutionary modelling approach, we investigate the dynamical 343 
interplay between host resistance and pathogen virulence with a specific 344 
emphasis on the likely resistance trait underlying the observed shift in host 345 
phenotypes and evolution towards higher virulence.  346 
 347 
Chapter 3: Protective benefits of the immune response to 348 
M.gallisepticum 349 
Various studies have highlighted how a history of exposure to a pathogen can 350 
result in adaptive changes in immune responses(Best & Kerr, 2000; Kerr & 351 
McFadden, 2002). However, when pathogens have the ability to manipulate 352 
host responses, it is often unclear as to whether specific components of 353 
immunity are protective, or damaging (Sansonetti & Di Santo, 2007). 354 
Furthermore, certain aspects of the host immune response are often assumed 355 
to be protective, despite little evidence to suggest that they have a direct role 356 
in pathogen control. Such is the case with circulating anti-M.gallisepticum 357 
antibodies (IgY), for which no direct protective benefit has yet been found in 358 
poultry (Noormohammadi et al., 2002), and for which the benefit has not yet 359 
been tested in house finches. Using measures of host pathology, host 360 
condition, measures of antibody concentration and RNA-sequencing to 361 
uncover differential gene expression, I examine the underlying differences in 362 
the host response to M.gallisepticum infection between exposed and 363 
unexposed populations in relation to the likelihood of recovery, pathogen 364 
clearance and mortality. In doing so, I uncover how a history of pathogen 365 
exposure has shaped the response to infection and provide precursory 366 
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evidence for how resistant hosts are able to avoid the damaging effects of 367 
infection.  368 
 369 
Chapter 4: Discussion and future directions 370 
Finally, in chapter 4 I discuss my findings in the context of what is known 371 
about host-pathogen evolution in house finches with MG, as well as the 372 
potential wider implications of my research in relation to other emerging 373 
infectious diseases. I conclude by suggesting some future directions in this 374 
area.   375 
 376 
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Abstract 407 
Emergent infectious diseases can have a devastating impact on host 408 
populations. The high selective pressures on both the hosts and the 409 
pathogens frequently lead to rapid adaptations in host resistance and 410 
pathogen virulence following an initial outbreak. However, it is often unclear 411 
whether hosts will evolve to decrease infection-associated fitness costs 412 
through a form of resistance that either prevents the establishment of infection 413 
(qualitative resistance) or limits its deleterious effects, for e.g. through immune 414 
functioning (quantitative resistance). Equally, the evolutionary repercussions 415 
these resistance mechanisms have for the pathogen are largely unknown. 416 
Here we take advantage of the well-documented outbreak of the highly 417 
pathogenic bacteria Mycoplasma gallisepticum in North American house 418 
finches. Using an evolutionary modelling approach, we investigate the 419 
dynamical interplay between host resistance and pathogen virulence. With a 420 
specific emphasis on the evolved resistance trait, we demonstrate that the 421 
observed rapid shift in host phenotypes following the outbreak is suggestive of 422 
strong selection pressure to reduce infection-associated mortality. This in turn 423 
created the ecological conditions that selected for increased bacterial 424 
virulence. Our results thus suggest that quantitative host resistance, which 425 
inadvertently helps to maintain high levels of disease prevalence in the 426 
population, is the key factor underlying the evolutionary interactions in this 427 
natural host-pathogen system.  428 
  429 
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Introduction 430 
Antagonistic interactions between hosts and pathogens can give rise to 431 
intense selection pressures and trigger rapid evolutionary changes in both 432 
(Buckling & Rainey, 2002; Paterson et al., 2010). This is particularly true in 433 
the context of novel disease outbreaks, in which potentially devastating 434 
impacts on the host population are expected to feed back to the pathogen 435 
through a rapidly changing host environment (Lively, 1989; Best & Kerr, 2000; 436 
Paterson et al., 2010). When faced with high infection-associated fitness 437 
costs, hosts can evolve either to prevent the establishment of infection, 438 
referred to as qualitative resistance, or limit its deleterious effects, referred to 439 
as quantitative resistance, through immune function (Gandon & Michalakis, 440 
2000; Sepil et al., 2013). Quantitative resistance is a term used to describe a 441 
scenario where by all hosts can become infected with a parasite, but resistant 442 
hosts are harmed less through traits that reduce the performance of a parasite 443 
in resistant hosts; differing to tolerance, which reduces the fitness costs of 444 
infection (Koskela et al., 2002). For example, quantitative resistance is 445 
conferred through specific MHC-supertypes associated with a reduction of 446 
parasitaemia (parasite load) in great reed warblers (Acrocephalus 447 
arundinaceus) (Westerdahl et al., 2012) and great tits (Parus major) (Sepil et 448 
al., 2013) infected with Plasmodium parasites. Evidence for the evolution of 449 
different resistance strategies has been observed in many species; however, 450 
whether hosts will evolve qualitative or quantitative resistance, particularly in 451 
response to an emerging disease, remains largely unknown (Gandon & 452 
Michalakis, 2000).  453 
	 18	
Due to the close ecological relationship between pathogens and their hosts, 454 
the type of host evolutionary responses to infection is expected to impact 455 
pathogen exploitation strategies and subsequent evolution of virulence (the 456 
reduction to host fitness during infection) (Read, 1994; Roy et al., 2000). 457 
Previous theoretical studies that distinguish host responses to infection as 458 
either preventing or limiting pathogen exploitation through reduced 459 
susceptibility or immune function (resistance), or offsetting infection-460 
associated fitness costs (tolerance), have yielded useful predictions as to 461 
when we might expect evolution towards a high or low virulence strategy (Roy 462 
et al., 2000; Miller et al., 2006; Best et al., 2014). However, we still lack a full 463 
understanding of the consequences of different resistance mechanisms (i.e., 464 
qualitative versus quantitative) on the evolution of pathogen virulence, 465 
particularly in wild populations with recurring epidemics.  As certain resistance 466 
alleles are expected to be advantageous only when the pathogen is present 467 
(Westerdahl et al., 2012), cycles of disease prevalence are likely to effect 468 
host-pathogen evolutionary trajectories.  469 
Pathogens are generally assumed to maximise their fitness (in terms of their 470 
basic reproductive number, R0) by optimising the trade-off between 471 
transmission rate and infection duration. Therefore, optimal virulence is highly 472 
dependent on these two factors. For example, a high proportion of 473 
qualitatively resistant hosts in a population will decrease overall parasite 474 
prevalence, which limits transmission opportunities and has thus been 475 
predicted to select for lower virulence (Baalen, 1998; Gandon & Michalakis, 476 
2000). On the other hand, quantitative resistance traits, which permit 477 
infections but decrease infection duration, for example through immune 478 
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activation, are expected to select for higher virulence (Baalen, 1998; Gandon 479 
& Michalakis, 2000; Gandon et al., 2002). What these studies highlight is that 480 
evolution of host resistance and pathogen virulence are intricately linked and 481 
require further investigation. 482 
The outbreak of the bacterium Mycoplasma gallisepticum in North American 483 
house finches (Heamorhous mexicanus) mid-1990s following a jump from 484 
poultry provides us with a unique opportunity to disentangle the evolutionary 485 
interplay between host resistance and pathogen virulence in a natural system. 486 
The ensuing epizootic of severe conjunctivitis led to the death of millions of 487 
house finches (Luttrell et al., 1998; Hochachka & Dhondt, 2000; Kollias et al., 488 
2004; Dhondt et al., 2005) and was followed by the rapid evolution of host 489 
resistance, which spread from ~20% to ~80% within 12 years following the 490 
outbreak (Bonneaud et al., 2011; Adelman et al., 2013). Experimental studies 491 
showed that house finches from disease-exposed populations displayed lower 492 
pathogen load following infection than finches from disease-unexposed 493 
populations, as well as gene expression changes in immune-associated 494 
tissue that were consistent with increased resistance to infection (Wang et al., 495 
2006; Bonneaud et al., 2011, 2012b). The underlying mechanism of 496 
resistance and whether it confers protection from infection establishment 497 
and/or from infection-induced morbidity or mortality is still unknown, however. 498 
Furthermore, parallel changes in bacterial virulence were also observed, with 499 
virulence, estimated as the severity of clinical symptoms, increasing over the 500 
course of the epizootic (Hawley et al., 2013). If and how the spread of host 501 
resistance contributed to increased virulence over time remains to be 502 
established. 503 
	 20	
Here we used a modelling approach to investigate the consequences of 504 
different types of host resistance on temporal changes in host evolution, 505 
disease prevalence and pathogen virulence using the M. gallisepticum - 506 
house finch disease system. Building on previous findings of rapid resistance 507 
evolution in this system, this approach enabled us to test hypotheses 508 
generated in previous theoretical studies (Gandon & Michalakis, 2000) to an 509 
important and well-characterised avian system. We investigate the effects of 510 
qualitative resistance traits that prevent infection versus quantitative 511 
resistance traits that either limit disease severity and thus transmissibility or 512 
simply reduce infection-associated mortality on resulting patterns of host 513 
resistance and parasite virulence evolution. Our results suggest that the 514 
observed spread of host resistance was the result of strong selection pressure 515 
to reduce M. gallisepticum induced mortality, which in turn provided the 516 
competitive advantage for more virulent bacteria.   517 
 518 
Methods 519 
In order to investigate the evolutionary dynamics of host resistance and 520 
pathogen virulence, we developed a two-strain, two-phenotype SIRS model 521 
with seasonal forcing. We divided the host population, N (which is not 522 
assumed to remain constant), into two broad categories, resistant (Nr) and 523 
non-resistant (Nnr) hosts, with resistant hosts assumed to carry a resistance 524 
trait offering lower susceptibility to infection, faster infection clearance rate or 525 
lower disease-associated mortality. Hosts can become infected with either a 526 
high virulence strain (h) or a low virulence strain (l) of M. gallisepticum and 527 
	 21	
transmission is frequency dependent (proportional to !/!). For simplicity, we 528 
assumed that upon recovery birds gain full but waning immunity against 529 
reinfection and any differences in pathogen load that may occur between 530 
resistant and non-resistant hosts does not affect their capacity to transmit. 531 
Interactions between strains, such as partial cross-immunity or super-532 
infection, were not considered. The rate of change in the number of 533 
susceptible (!!",!), infected (!!",!!,!  ) and recovered birds (!!",! ) was given by 534 
the following set of differential equations: 535 
!!!"!" = ! ! !!" − !(!) !!! + !!"! +  !! !!! + !!"! !!"! + !!!" − !(!)!!" 
!!!!" = ! ! !! − !!!(!) !!! + !!"! +  !! !!! + !!"! !!! + !!! − !(!)!! 
!!!"!!" = ! ! !!! + !!"! !!"! − !!!"! − !!!"! − !(!)!!"!  
!!!"!!" = !!! ! !!! + !!"! !!"! − !!!!!"! − !!!!!"! − !(!)!!"!  
!!!!!" = !!! ! !!! + !!"! !!! − !!!!!! − !!!!!! − !(!)!!!  
!!!!!" = !!!!! ! !!! + !!"! !!! − !!!!!!!! − !!!!!!!! − !(!)!!! 
!!!"!" = ! !!"! + !!!!"! − !!!" − !(!)!!" 
!!!!" = !!! !!! + !!!!! − !!! − !(!)!! 
 536 
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where b(t) is the seasonal birth rate, !(!) is the seasonal transmission 537 
coefficient, σ is the recovery rate, ! is the disease-associated mortality rate, 538 
and !(!) is the natural and season-dependent death rate. Supplementary 539 
Figure S1 illustrates this model as a flow diagram. 540 
We used two sets of scaling factors to investigate the (independent) effect(s) 541 
of host resistance (!!,!!,!!) and pathogen virulence (!!, !!, !!). For example, 542 !!(≥ 1) describes the relative increase in the recovery rate for birds of the 543 
resistant phenotype, whereas !!(≥ 1) describes the relative increase in the 544 
transmission rate of birds infected with the more virulent strain. Considering 545 
host susceptibility, recovery rate and mortality rate independently allows us to 546 
investigate the full spectrum of resistance, from purely qualitative (!! <547 1,!!,!! = 1 , i.e. decrease susceptibility but equal infection length and 548 
mortality rate) to purely quantitative ( !! = 1,!! ≥ 1,!! ≤ 1 , i.e. equal 549 
susceptibility but either increase clearance and/or decreased mortality). 550 
Seasonal changes in house finch demography and aggregation rates have 551 
previously been shown to be important in generating semi-annual cycles of M. 552 
gallisepticum prevalence (Altizer et al., 2004; Hosseini et al., 2004). We 553 
therefore incorporated seasonality into our model by using time-dependent 554 
birth, death and transmission rates (see Supplementary Figure S2). Birth 555 
rates, ! ! , peak in July / August, whereas mortality, ! ! , is highest during 556 
winter months (see Supplementary Figure S2). Driven by social aggregation 557 
during the mating season and the formation of winter foraging flocks, we 558 
assumed that transmission rates, ! ! , fluctuate semi-annually (Altizer et al., 559 
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2004). The seasonal birth, mortality and transmission rates are given as 560 
follows: 561 
! ! = !! sin ! − 0.1 ! !! 
! ! = !! 0.4+ 0.6 (sin ! − 0.5 ! !! 
! ! = !!(0.2+ 0.8 sin ! − 0.35 ! !! + sin ! + 0.35 ! !!  
with !! , !!  and !!  denoting the peak birth, death and transmission rates, 562 
respectively. !! , !!  and !!  are (even-valued) shape parameters that 563 
determine the length of a season. 564 
We initialised the model assuming a 20% background prevalence in host 565 
resistance (in line with empirical observations;(Bonneaud et al., 2011)) and 566 
equal prevalence of high and low virulent strains of M. gallisepticum. Host 567 
recovery rate was set at 2 months (Bonneaud, unpublished) and the loss of 568 
immunity was set at 14 months (Kollias et al., 2004). Table 1 provides a 569 
summary of the model’s parameters.  570 
 571 
 572 
 573 
 574 
 575 
 576 
 577 
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Table 1: Model Parameters. 578 
Parameter Description Value   Range ! recovery rate (per year) 6 [5,10] ! rate of loss of immunity (per year) 0.9 [0.5,1.5] ! disease associated death rate (per year) 3 [2,4] 
kt shape parameter (transmission) 20 - 
kb shape parameter (birth) 80 - 
kd shape parameter (death) 10 - !! max transmission coefficient 48 - 
b0 max birth rate (per year) 3.61 - ! 0 max death rate (per year) 0.3 - !! susceptibility scale factor (resistance) 1 [0,1] !! recovery scale factor (resistance) 1 [1,2] !! mortality scale factor (resistance) 0.1 [0,1] !! transmissibility scale factor (virulence) 1.2 [1,2] !! recovery scale factor (virulence) 1 [0,1] !! mortality scale factor (virulence) 2 [1,5] 
 579 
 580 
Results 581 
 (a) General model behaviour assuming quantitative resistance 582 
First, we simulated our model considering all hosts as equally susceptible to 583 
becoming infected, but with resistant and non-resistant hosts differing in their 584 
infection-induced mortality rates. As shown in Figure 1, this model captured 585 
the observed qualitative dynamics in disease prevalence over time, with the 586 
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two distinct peaks in spring and autumn corresponding to seasonal increases 587 
in host population densities and aggregation, and hence in transmission 588 
opportunities (Hosseini et al., 2004).  589 
 590 
Figure 1. Short-term dynamics of population level M. gallisepticum 591 
infection prevalence. (a) Seasonal component of Empirical prevalence data 592 
adapted from (Altizer et al., 2004; Hosseini et al., 2004). Red line represents 593 
Southern regions of the Eastern United states, blue line represents central 594 
regions and green line represents northern regions. (b) Model simulation 595 
capturing the semi-annual dynamics driven by seasonal fluctuations in host 596 
densities and aggregation rates. Parameter values: !! = !,!! = !,!! =597 !.!, ,!! = !; other parameter values as in Table 1. 598 
 599 
Following the initial outbreak, we found that the number of susceptible hosts 600 
and the total host population size decreased significantly as a direct result of 601 
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high infection-associated mortality rates (Figure 2a). This decrease in the 602 
number of susceptible hosts then led to a substantial decline in disease 603 
prevalence (Figure 2b). When we stratified the host population into resistant 604 
and non-resistant phenotypes (Figure 2c), our model revealed rapid 605 
phenotypic changes in the host population in line with previous empirical 606 
studies (Bonneaud et al., 2011), with resistant hosts reaching ~80% 607 
prevalence after around ten years post-emergence. In parallel, while the low 608 
virulence pathogen strain dominated during the initial phase of the epizootic, it 609 
became outcompeted by the more virulent strain after around 8 years (Figure 610 
2b and d). These results therefore suggest that strong pathogen-induced 611 
selection pressure and the subsequent increase in resistant host phenotypes 612 
in the population created the conditions for a more virulent pathogen strain to 613 
emerge and dominate (Figure 2d, S3). 614 
 615 
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 616 
Figure 2. Model simulations of host and pathogen population dynamics. 617 
(a) Following disease emergence there is a significant decrease in the 618 
number of susceptible hosts (solid line) and total host population size (dashed 619 
line). (b) Number of individuals infected with the low virulence (solid line) and 620 
high virulence strain (dashed line) over time showing initial dominance of the 621 
low virulent strain, which eventually gets outcompeted. (c) Change in the 622 
proportion of the host population with a non-resistant or resistant phenotype 623 
(Nnr and Nr, respectively). (d) Proportion of host population infected with low 624 
or high virulence strains over time showing an initial expansion of the low 625 
virulence strain until the number of resistant hosts has reached a critical 626 
threshold that tips the balance in favour of the more virulent strain. Parameter 627 
values: !! = !,!! = !,!! = !.!,!! = !; other parameter values as in Table 1. 628 
 629 
Similar model behaviour was obtained when assuming quantitative resistance 630 
as an increase in recovery rate, which equally selected for host resistance in 631 
the population, albeit at a much-reduced rate (Supplementary Figure S4). 632 
What these results suggest is that disease prevalence needs to be maintained 633 
at a sufficiently high level for the fast and continued selection of host 634 
resistance traits. That is, both a reduction in susceptibility and a reduction in 635 
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the infectious periods drastically reduce the number of susceptible hosts and 636 
hence disease transmission, which consequently lowers the selection 637 
pressure in the population. 638 
 639 
(b) Qualitative resistance reduces the speed of phenotypic change  640 
We next tested the effects of different resistance strategies on the host’s 641 
evolutionary response to infection. As shown in Figure 2c and 3a (top graph), 642 
quantitative resistance in the form of a reduction in disease-associated 643 
mortality causes a rapid change in host phenotype distribution, with resistant 644 
birds increasing in frequency from ~20% to ~80% in just ten years in line with 645 
empirical observations. Instead, when modelling resistance as a difference in 646 
susceptibility to becoming infected, we found a marked reduction in the speed 647 
of resistance evolution, with resistant hosts only making up about half of the 648 
population ten years after disease emergence (Figure 3a, bottom graph). 649 
Running a sensitivity analysis over these two resistance traits (relative 650 
susceptibility, ρ1, and relative mortality, ρ3) confirmed that resistant birds need 651 
to have similar rates of infection, but a much reduced risk of mortality from 652 
disease related causes, in order to explain the observed shift in host 653 
phenotypes (Figure 3b).  654 
 655 
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 656 
Figure 3. Effect of relative susceptibility and mortality on selection of 657 
host resistance phenotype. (a) Model output for the frequency of resistant 658 
(solid line) versus non-resistant (dashed line) host phenotypes over time. 659 
Reduction of infection-associated mortality leads to the rapid selection of 660 
resistant phenotypes (HR, top graph), whereas a reduction of susceptibility to 661 
infection slows down the selection for resistance (LR, bottom graph). (b) The 662 
effect of relative mortality and relative susceptibility of resistant birds on the 663 
prevalence of the resistant phenotype at ten years post emergence. Low 664 
frequencies of resistant phenotypes occur when mortality is similar between 665 
the two host phenotypes and when resistant hosts are significantly less 666 
susceptible to infection (LR). High levels of population-level resistance occur 667 
when resistant and non-resistant hosts are equally likely to become infected 668 
but experience significantly lower mortality (HR). Parameter values: !! =669 !,!! = !; other parameter values as in Table 1, except in (a): !! = !.!,!! =670 !.! (top) and !! = !.!,!! = !.! (bottom). 671 
 672 
(c) Host resistance and its effect on virulence evolution 673 
Finally, we considered the selective impact of host resistance on the evolution 674 
of pathogen virulence. As demonstrated above (Figure 2b and d) and in line 675 
with empirical observations, assuming quantitative resistance as a decrease 676 
in mortality can cause the selection of more virulent bacteria over time. 677 
However, the exact conditions that favour a more virulent strain crucially 678 
depend on its mortality rate relative to that of a less virulent strain, !!and the 679 
extent to which infection-induced mortality is reduced in resistant hosts, !!. To 680 
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demonstrate this we ran a sensitive analysis over these two scaling factors 681 
(!! and !!) and recorded the relative frequency of both strains over time 682 
(Figure 4). As shown in Figure 4a, under the assumption that disease-683 
associated mortality is much higher for the more virulent strain, selection will 684 
favour the less virulent strain as the gain in transmissibility is outweighed by 685 
the rapid loss of infected hosts. On the other hand, if the mortality rates from 686 
infection with either strain are not too dissimilar and resistant hosts are 687 
significantly more protected against infection-induced mortality, more virulent 688 
bacteria will have the fitness advantage. 689 
Crucially, whilst the other two resistance strategies (reduced susceptibility or 690 
reduced infection length through faster recovery) can also select for increased 691 
virulence (Supplementary Figures S5 and S6, respectively), the conditions 692 
under which this may take place are such that either the disease and/or host 693 
population goes extinct, or the rate of change in host phenotype distribution is 694 
too slow to be compatible with the data. Taken together, our results thus 695 
suggest that quantitative resistance, which offers the host protection against 696 
disease associated mortality, was the most likely factor underlying the 697 
observed co-evolutionary dynamics in this wildlife disease system. 698 
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 699 
Figure 4. Effects of host resistance on pathogen virulence evolution. (a) 700 
Model output showing the number of birds infected with the low (blue) and 701 
high (red lines) virulence strain of M. gallisepticum. When resistant and non-702 
resistant host phenotypes experience the same levels of infection-associated 703 
mortality the more virulent strain will go extinct (top graph), whereas greatly 704 
reduced infection associated death rates in resistant hosts can provide a 705 
fitness advantage for more virulent bacteria (bottom graph). (b) The effect of 706 
relative mortality caused by the high virulence strain versus the relative 707 
mortality in resistant hosts on the evolution of virulence, determined as the 708 
frequency of the high virulent strain at ten years post emergence. Parameter 709 
values: !! = !,!! = !; other parameter values as in Table 1 as in Table 1, 710 
except in (a): !! = !,!! = !.! (top) and !! = !,!! = !.! (bottom). 711 
 712 
Discussion 713 
In the present study, we identified the set of conditions that could explain the 714 
rapid selection of host resistance and parallel increased pathogen virulence 715 
following the epizootic outbreak of M. gallisepticum in North American house 716 
finches. Specifically, we have demonstrated that neither a reduction in host 717 
susceptibility to M. gallisepticum infections, nor an increase in parasite 718 
clearance rates, is compatible with the empirical data. Indeed, the impact of 719 
each on infection prevalence would cause a reduction in disease-induced 720 
selection pressure to the extent that we would no longer be able to observe 721 
shifts in both host and pathogen phenotypes. Instead, our results suggest that 722 
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the rapid, disease-induced selection of host resistance traits based on 723 
reducing infection-associated mortality, for instance through a lowering of 724 
pathogen load, was the key driver for the subsequent increase in bacterial 725 
virulence in this important host-pathogen system.  726 
Our results are in line with both empirical observations and theoretical 727 
predictions. Experimental work on the evolution of resistance in house finches 728 
has shown that resistance spread rapidly from standing genetic variation in 729 
less than 12 years of disease exposure (Farmer et al., 2005; Hawley et al., 730 
2007; Bonneaud et al., 2011). This speed of host adaptation suggests that the 731 
disease must have imposed a strong selection pressure on the host 732 
population, a hypothesis further supported by the high rates of mortality 733 
observed in the wild following outbreak (Hochachka & Dhondt, 2000). In 734 
accordance, our modelling study demonstrates that for a phenotypic change 735 
to occur in the host population, house finches must incur a high fitness cost 736 
from being infected with M. gallisepticum, with non-resistant finches paying a 737 
higher cost than resistant ones.  738 
The results of our model would suggest that resistant finches not only 739 
experience reduced mortality when infected, but that they should also display 740 
a level of susceptibility to infection similar to that of non-resistant birds. When 741 
host resistance is modelled as reduced susceptibility to infection, its negative 742 
impact on population-level infection prevalence is indeed too great to maintain 743 
the selection pressure that would account for the rapid change in host 744 
phenotype frequencies. A similar outcome was obtained when modelling 745 
resistance as increased recovery rate: selection pressure on host resistance 746 
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subsequently dropped, thereby slowing down the speed of host phenotypic 747 
change. The most likely resistance trait under selection in this system 748 
therefore consists of a reduction in infection severity, which is compatible with 749 
the notion of quantitative resistance.  750 
It has previously been proposed that qualitative resistance, which lowers a 751 
host’s susceptibility to infection, should select for decreased pathogen 752 
virulence and that this effect should positively increase with the proportion of 753 
resistant individuals in the host population (Gandon & Michalakis, 2000). 754 
Although we also found some conditions under which reduced susceptibility 755 
could lead to an increase in virulence, the parameter regions where this 756 
occurred resulted in model behaviours that are incompatible with the 757 
observed data, leading either to (host or pathogen) population extinction or to 758 
a reduction in selection pressure precluding major shifts in host phenotype 759 
frequencies. 760 
A number of studies to date have focussed on characterising the immune 761 
response of wild populations to emerging infectious diseases (Kerr & 762 
McFadden, 2002; Gregory et al., 2005; Bonneaud et al., 2012b). The 763 
canonical example of the parallel evolution of host resistance and pathogen 764 
virulence following disease emergence is the eradication attempt of European 765 
rabbits (Oryctolagus cuniculus) of Australia using the Myxoma virus. Following 766 
the release of highly virulent strains in 1950, which resulted in a dramatic 767 
decline of the rabbit population by over 99% (Marshall et al., 1955), virulence 768 
was found to decrease and resistance via enhanced innate immunity to 769 
spread in the host population (Best & Kerr, 2000). Although these findings 770 
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suggest that quantitative resistance may have driven the evolution of 771 
resistance in this case, genes underlying both qualitative and quantitative 772 
forms of resistance can be found in the wild, suggesting a role of both in 773 
shaping host-pathogen interactions and coevolution. For example, a study on 774 
wild great tits showed that different super types of the same MHC gene can 775 
confer either qualitative or quantitative resistance to avian malaria (Sepil et 776 
al., 2013). Determining which form of resistance is under selection will shed 777 
light on the phenotypic change expected in the host population, as well as on 778 
the pathogen’s evolutionary trajectory (Gandon & Michalakis, 2000). 779 
An important aspect influencing the long-term evolutionary outcome of host-780 
pathogen interactions are the costs associated with either form of resistance. 781 
It has been proposed that resistance through protective immunity is expected 782 
to evolve only when the cost of mounting the immune response is lower than 783 
the cost of being infected (Antonovics & Thrall, 1994; Boots & Bowers, 2004; 784 
Viney et al., 2005). House finches from populations that evolved resistance 785 
have previously been found to lose more body mass following experimental 786 
infections with M. gallisepticum than finches from unexposed populations 787 
(Bonneaud et al., 2012a). The fact that resistance has spread despite this 788 
indicates that the fitness benefit of resisting either infection or infection-789 
associated morbidity ultimately outweighs the shorter-term energetic cost of 790 
resistance. Hence, while our model does not include costs associated with 791 
resistance, we do not expect such costs to impact the results of this study 792 
other than by influencing the probability that resistance will go to fixation and 793 
that resistant phenotypes will decline in frequency once the disease goes 794 
extinct.  795 
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In conclusion, our results reiterate the important influence that the 796 
mechanisms underlying host resistance can have on the mode and tempo of 797 
host phenotypic change and pathogen virulence evolution. Distinguishing 798 
between different forms of resistance in plants is common-place (Ewing et al., 799 
2000; Ramalingam et al., 2003; Hein et al., 2009), but has only scarcely been 800 
applied to animal or human disease systems despite its importance for public 801 
health. That is, many disease intervention measures that either prevent 802 
infections (e.g. vaccination) or enhance clearance (e.g. drug treatment) will 803 
effectively induce, or mimic, host resistance. Given the varying impacts of 804 
different forms of resistance on the evolution of pathogen virulence, 805 
inappropriate control measures can on occasion, result in undesirable 806 
outcomes, such as increases in pathogen virulence (Gandon et al., 2001) and 807 
disease severity (Stevens et al., 2007). Our study thus highlights the need for 808 
a more detailed investigation of the evolutionary host-pathogen interactions in 809 
order to minimise adverse effects of disease control.  810 
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Chapter 3:Protective benefits of the immune response to 811 
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Abstract 836 
The adaptive significance of immune components is now high priority on the 837 
research agenda of many ecologists and evolutionary biologists, because 838 
defining individual levels of host resistance is impossible without knowledge of 839 
the efficacy of immune measures in combating infection.  Protective effects of 840 
immune measures are often assumed, although the extent to which they 841 
confer protection likely depends on the history of pathogen exposure, as well 842 
as the specific way in which the pathogen causes damage. Using RNA-seq 843 
based transcriptomics, we assessed differential expression of immune and 844 
immune associated genes between finches originating from unexposed and 845 
coevolved house finch populations to infection. In addition, we assess the 846 
efficacy of an easily measured immune component, systemic antibody (IgY) in 847 
protection from mortality, symptom severity and the likelihood of increased 848 
recovery or pathogen clearance. Stark inter-population differences in 849 
transcriptional profiles are demonstrated, consistent with exposed populations 850 
exhibiting an enhanced ability to avoid immune-pathological effects of 851 
infection. In addition, we find significantly higher IgY concentration in exposed, 852 
relative to unexposed, finch populations. However, we find no protective 853 
benefit to increased circulating IgY concentrations, suggesting the increased 854 
humoral response may be a by-product of the up-regulation of another 855 
immune component.  856 
 857 
 858 
 859 
 860 
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Introduction 861 
Infectious diseases exert profound selection pressure on their hosts; 862 
influencing many aspects of host biology from reproductive modes (Liersch & 863 
Schmid-Hempel, 1998) to behaviour (Berdoy et al., 2000). Response to 864 
pathogen exposure includes a suite of combative defense mechanisms, which 865 
together make up the immune response. Evidence for the rapid evolution of 866 
these responses in wild populations is growing; from rabbits with Myxoma 867 
virus (Kerr & McFadden, 2002) to amphibians with chytridiomycosis  (Savage 868 
& Zamudio, 2016). Formerly the exclusive domain of immunologists, the study 869 
of the adaptive significance of immune responses has become a high priority 870 
on the research agenda of many evolutionary ecologists, because the costs 871 
and benefits of the type and strength of response elicited strongly influence 872 
the fitness of the host (Sheldon & Verhulst, 1996). In spite of this, the 873 
characterization of immune responses of wild populations to emerging 874 
diseases is rare, largely due to a scarcity of techniques available to do so, 875 
particularly in non-model organisms.  876 
 877 
One method for overcoming the lack of availability of reference genomes in 878 
non-model organisms is to use RNA-seq based transcriptomics (Grabherr et 879 
al., 2013). However, this has scarcely been applied to wild systems, largely 880 
due to the inability to control conditions in wild populations and due to the 881 
potential for environmental contamination. However, this method is increasing 882 
in popularity in a range of taxa from birds (Videvall et al., 2015) to amphibians 883 
(Campbell et al., 2018). As hosts live in naturally varying environments, the 884 
extrapolation of laboratory results to wild populations is often tenuous or not 885 
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completely suitable (Pedersen & Babayan, 2011). Never the less, in spite of 886 
new techniques that are now available to characterize immune responses, it is 887 
often unclear as to whether individual immune measures are protective, or if 888 
they reflect individual levels of host resistance.  889 
 890 
Often, antibody levels are used as a proxy for resistance in wild animals, due 891 
to the tractability of taking fecal or hematological samples in the field. 892 
Antibodies (also called Immunoglobulins), are produced by B lymphocytes in 893 
response to specific antigens (Janeway et al., 2001) and act to control 894 
invading pathogens through various mechanisms, including neutralization 895 
(Mazanec et al., 1992; Palladino et al., 1995; Teoh et al., 2012), prevention of 896 
adherence (Wallace et al., 1991)or the activation of the complement cascade 897 
(Diebolder et al., 2014). However, whilst the humoral response is expected to 898 
be protective, evidence suggests that antibodies may not always be effective 899 
against certain pathogens (Amorim et al., 2016; Dumke & Jacobs, 2016), or 900 
that high antibody titres can be associated with more severe symptoms (Wells 901 
et al., 2014). In many cases, it is also unclear to what extent levels of antibody 902 
correlate with levels of host resistance.  903 
 904 
When diseases emerge in a novel host, it is possible to document how 905 
coevolutionary history of exposure changes the mechanisms by which hosts 906 
overcome infection. One such system is the bacterial pathogen Mycoplasma 907 
gallisepticum in North American house finches (Haemorrhus mexicanus). A 908 
common pathogen of poultry, it emerged in Eastern finch populations in 1994 909 
(Ley et al., 1996). In house finches, M.gallisepticum causes conjunctivitis and 910 
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a disease of the upper respiratory tract. When the pathogen first emerged in 911 
finches, it resulted in the deaths of millions of birds (Hochachka & Dhondt, 912 
2000). By the early 2000s, M.gallisepticum had spread to Western finch 913 
populations, although epidemic spread was slowed over the Great Plains due 914 
to relatively low house finch densities (Sauer et al., 2012). In fact, some 915 
populations, such as finches in Tempe, Arizona remain unexposed to this day 916 
(Staley et al. 2017, in press). Changes to the dynamics of M.gallisepticum 917 
prevalence in Eastern house finch populations to endemic levels has been 918 
attributed in part to the rapid spread of host resistance, occurring within just 919 
12 years (Bonneaud et al., 2011, 2012b).  920 
 921 
Much of what is known about the immune response to M.gallisepticum is from 922 
the poultry literature. M.gallisepticum infection is associated with suppressing 923 
certain aspects of immunity (Mohammed et al., 2007) including T-cell activity 924 
2 weeks post inoculation (Ganapathy & Bradbury, 2003), and has been shown 925 
to induce inflammatory responses, thus increasing number of tissue lesions 926 
(Ley, 2008). During the early stages of the epizootic in house finches, Eastern 927 
birds from Alabama displayed transcriptional responses to infection that were 928 
similar to those from unexposed, Western finches from Arizona. However, in 929 
the years following, Eastern birds began to differ in their responses. Previous 930 
studies have demonstrated that these individuals were able up-regulate genes 931 
involved in innate and acquired immunity, and harbored lower conjunctival 932 
pathogen loads (Bonneaud et al., 2011, 2012b). These results indicated that 933 
differences in transcriptional response between populations did not simply 934 
arise through ecological differences, but rather accompanied the evolution of 935 
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resistance. However, the efficacy of innate and acquired immune responses 936 
in conferring survival and recovery still remain to be elucidated.   937 
 938 
To examine the efficacy of innate and acquired responses in fighting 939 
M.gallisepticum infection, we conducted an experimental infection and 940 
examined systemic antibody (IgY) concentrations in relation to recovery from 941 
symptoms (measured by eye-lesion severity), pathogen clearance (measured 942 
by PCR-detection of the pathogen) and mortality. Although local antibody 943 
concentration has been previously shown to have a role in mediating the 944 
control of M.gallisepticum infection in chickens (Gaunson et al., 2006), no 945 
such protective role of local or circulating antibodies has yet been established 946 
in house finches. We next examined whole-blood gene expression profiles, as 947 
blood has recently been shown to be a useful tissue in detecting immune 948 
stimulation in passerine birds (Meitern et al., 2014). By comparing birds from 949 
Eastern (Alabama) and Western (Arizona) populations, we investigate how a 950 
history of disease exposure has shaped the response to infection in Eastern 951 
birds.  952 
 953 
We make several broad predictions with regards to population differences in 954 
immune response, and the potential protective benefits. First, our results 955 
would suggest a potential, protective benefit of circulating antibodies if: i) 956 
antibody concentration is significantly higher in finches originating from 957 
Alabama at one or all of the time points measured (if this occurs at a time 958 
point early-on in infection, this may be suggestive of an enhanced speed of 959 
antibody production), or ii) increased antibody responses are associated with 960 
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decreased mortality, increased recovery from symptoms or increased 961 
pathogen clearance. Furthermore, if differences in transcriptional profiles 962 
between populations show finches from Alabama decreasing the inflammatory 963 
response, or up-regulating genes associated with adaptive immunity, this will 964 
suggest that avoidance of immune-manipulation by M.gallisepticum has 965 
played a role in the evolution of host resistance.  966 
 967 
Methods  968 
During the summer of 2015, wild house finches were captured from 969 
populations with no prior exposure to M. gallisepticum in Arizona (N=25; 13 970 
males and 12 females) and from populations that have been exposed to 971 
M.gallisepticum since disease outbreak in Alabama (N=25; 12 males and 13 972 
females) (Bonneaud et al submitted). Upon capture, lack of past and current 973 
infection was verified using serum plate agglutination assay (Luttrell et al., 974 
1996) and PCR amplification of M.gallisepticum DNA in choanal swabs 975 
(Luttrell et al., 1996; Roberts et al., 2001). All birds were brought back to 976 
aviaries at Arizona State University, where they were housed for the 977 
remainder of the experiment. 978 
 979 
Finches were infected with M.gallisepticum isolates from 2007 (N=16), 2011 980 
(N=16) and 2015 (N=18), with each isolate inoculated into 1 finch from 981 
Alabama and 1 finch from Arizona (Bonneaud et al submitted). Development 982 
of clinical symptoms was monitored by visually scoring eye lesion severity at 983 
both eyes (0–5 scale; (Kollias et al., 2004)) at 3, 6, 8, 14, 21, 25, 28 and 34 984 
days post-infection (dpi). Peak symptom severity was determined as the 985 
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maximum score reached over the course of the experiment. Birds that 986 
developed clinical symptoms of less than 4 (see below for rationale) and then 987 
returned to a symptom score of 0 during the course of the experiment were 988 
classified as having recovered.  989 
 990 
Clearance of M. gallisepticum was determined from conjunctival and tracheal 991 
swabs taken at 8, 14, 21 and 28 dpi and stored in 600 µL of RNAlater ® 992 
(Thermofisher Scientific) at -80°C; DNA was extracted from the swabs using 993 
Qiagen DNeasy Blood and Tissue kit (Tardy et al in prep). Amplification of M. 994 
gallisepticum DNA was performed on the DNA extracts from all swabs using 995 
mgc2 primers developed by (García et al., 2005). Birds were categorized as 996 
having cleared the infection if the swabs became negative during the 997 
experiment. 998 
 999 
At 14dpi, ~250 µL of whole blood was taken by brachial venipuncture. An 1000 
aliquot of blood was directly stored in Tempus™ Blood RNA tubes 1001 
(Thermofisher Scientific, Leicester, UK) at -80°C for subsequent RNA 1002 
extraction. We isolated serum from a second aliquot for ELISA through 1003 
centrifugation at 2000XG for 15 minutes at 4°C; serum was stored at -80°C. 1004 
 1005 
Host mortality was estimated based on the development of symptoms of 1006 
scores 4 or 5, as these would lead to blindness-associated death in the wild 1007 
(Bonneaud et al submitted). Therefore, when individuals reached peak 1008 
symptoms of scores 4-5, this was described as a mortality event. The 1009 
experiment was stopped at 35 dpi and all birds were euthanized as stipulated 1010 
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by home office licensing. Protocols were approved by Institutional Animal 1011 
Care and Use Committees (IACUC) of Auburn University (permit # PRN 2015-1012 
2721) and of Arizona State University (permit #15-1438R), and by Institutional 1013 
Biological Use Authorizations to Auburn University (# BUA 500). 1014 
 1015 
ELISA 1016 
Goat Polyclonal Passerine IgY-heavy and light chain Antibody (Bethyl 1017 
laboratories, Inc, TX, USA) was diluted to 1:1000 dilution according to 1018 
manufacturer protocol. The prepared antibody was then conjugated to a 1019 
visible proprietary HRP (horse radish peroxidase) ligand for visualization in 1020 
enzyme-linked immunosorbent assay (ELISA), according to instructions 1021 
accompanying the Lighting-Link® HRP Conjugation Kit (Innova biosciences, 1022 
Cambridge, UK) for an antibody: HRP molar ratio of 1:4.  1023 
 1024 
M.gallisepticum specific antibody detection was performed with ELISA, with 1025 
methods adapted from (Fassbinder-Orth et al., 2016). Finch serum samples 1026 
were diluted to 1:2400 in 1X sample conjugate diluent (Affinitech LTD, AR, 1027 
USA) and 100 µL of each sample was added to plate microwells bound with 1028 
inactivated M.gallisepticum antigen (Affinitech LTD). A standard curve of 1029 
pooled sample was run on each plate in a 2-fold dilution series from 1:200-1030 
1:6400. Samples were run in duplicate, and care was taken to ensure that 1031 
duplicates were distant from one-another to reduce variation caused by 1032 
evaporation and edge effects. Plates were washed three times in 1X wash 1033 
buffer (Bethyl laboratories, Inc), before adding 100 µL of the prepared HRP-1034 
conjugated Passerine IgY-heavy and light chain antibody, diluted to a 1035 
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1:10,000 concentration with sample conjugant diluent (Bethyl laboratories, 1036 
Inc). After incubation for one hour in darkness, the plate was washed three 1037 
times and 100 µL of TMB one component HRP microwell substrate (Bethyl 1038 
laboratories, Inc) was added to each well and incubated for 15 minutes in 1039 
darkness. The reaction was stopped with 100 µL of 0.18M H2SO4 and the 1040 
plate was read on a plate reader at 450nm within 30 minutes of stopping the 1041 
reaction.  1042 
 1043 
RNA isolation, cDNA library preparation and sequencing 1044 
Total RNA for ten birds infected with 2015 isolates of M.gallisepticum was 1045 
extracted by a guanidinium thiocyanate-phenol-chloroform method using 1046 
TRIzol® (Life Technologies, CA, USA). 100 µL of each whole blood sample 1047 
was lysed and homogenized in 1ml of TRIzol® by a 20 second bead ruptor 1048 
with silicone beads, before continuing with the standard TRIzol® protocol. 1049 
RNA was subsequently purified using the RNeasy Micro-Kit (Qiagen), 1050 
according to the manufacturer protocol, including DNase treatment and 1051 
subsequent spin-column clean-up. The quality and RNA concentrations of 1052 
each sample were determined by nano-drop (Thermofisher scientific), 1053 
followed by Qubit (Life Technologies). Final RNA concentrations of samples 1054 
were measured on a Bioanalyzer (Agilent, Manchester, UK), and checked for 1055 
an RNA integrity number (RIN) of >8.  1056 
After quality and quantity checks, library preparation and sequencing was 1057 
performed by Exeter University sequencing service. The libraries were 1058 
prepared from 500ng total RNA using the TruSeq stranded mRNA sample 1059 
preparation kit (Illumina Inc, Essex, UK) including poly-A selection. 1060 
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Transcriptome sequencing was performed on the Illumina HiSeq2500 1061 
platform, using a 125 base pairs sequencing run generating 458.5 million 1062 
paired-end reads.  1063 
 1064 
De novo transcriptome assembly  1065 
Raw read quality was determined using FastQC software v0.11.6 1066 
(https://www.bioinformatics.babraham.ac.uk/projects/download.html#fastqc). 1067 
Adapters from each sample were removed individually using TrimGalore! 1068 
v0.4.4, which removed poor-quality reads from the 3’ end of the sequences 1069 
and subsequently looked for and removed the standard Illumina adapters 1070 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/). The 1071 
trimmed reads across all ten samples were then combined into a single 1072 
database. Trinity v2.5.1 was run in strand specific (RF) mode to generate 1073 
three assemblies, of which the best was selected through computing the N50 1074 
length statistics and proportion of reads mapping to the assembly (Honaas et 1075 
al., 2016).  1076 
 1077 
Transcript abundance estimation and gene expression analysis 1078 
Results of the de novo transcriptome assembly were used to perform 1079 
expression analysis for each sample, due to the lack of a fully assembled 1080 
H.mexicanus reference genome. Tools embedded in the Trinity differential 1081 
expression module were used to do so, including Bowtie2 for mapping reads 1082 
against the reference transcriptome and abundance estimation calculation 1083 
using RSEM. Differential expression levels between unexposed (Arizona) and 1084 
adapted (Alabama) were determined using the RSEM read counts matrix, 1085 
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alongside the Bioconductor edgeR package. Only the isoforms represented 1086 
with at least a four-fold change and an adjusted P-value (FDR) of 0.01 were 1087 
considered as differentially expressed in the comparison between individuals 1088 
from Eastern and Western populations.  1089 
 1090 
Functional annotation of the transcriptome  1091 
The functional annotation of each predicted differentially expressed protein-1092 
coding sequence was performed with a search against the nonredundant 1093 
(NR) database on NCBI using BLAST (http://www.blast2go.com) with an E-1094 
value threshold of 1e-3 (Conesa et al., 2005). Blast2GO was also used to 1095 
search through the NR database and assign Gene Ontology (GO) terms for all 1096 
differentially expressed transcripts. GO biological processes were also 1097 
assigned to each transcript through manually searching the Uniprot database.  1098 
 1099 
We found a total of 138 differentially expressed candidate transcripts that 1100 
were differentially expressed with a log-fold change of >4 between 1101 
populations (P<0.01). The significance of differences in expression of these 1102 
transcripts was confirmed by the Benjamini and Hochberg FDR corrections 1103 
(FDR<0.01). Of these, 103 showed high similarity to known vertebrate 1104 
homologues or hypothetical protein sequences in other species (E-value cut-1105 
off of 1e-3; Table S7). The remaining 35 transcripts were not successfully 1106 
matched to known protein sequences.  1107 
 1108 
The aim of our study was to test whether there is differential expression of 1109 
genes directly linked to the response to infection between populations. 1110 
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Previous studies have demonstrated that there are energetic costs associated 1111 
with immune responses (Bonneaud et al., 2012a), as well as differences in 1112 
the expression of immune-associated genes in spleen tissue (Bonneaud et 1113 
al., 2011, 2012b). Therefore, we further processed these 103 annotated 1114 
transcripts by carrying out literature searches to identify 20 specific transcripts 1115 
associated with immune function, angiogenesis, autophagy, glucose 1116 
metabolism, inflammation, mitochondrial electron transport chain, proteolysis 1117 
and stress/damage, to assess underlying differences in response to infection, 1118 
attributable to differences in history of pathogen exposure (Table 2).  1119 
 1120 
Statistical analyses  1121 
All statistical analyses were conducted using RStudio v0.99.902 (R Studio 1122 
team, 2017). Six individuals exhibited vastly higher antibody concentration at 1123 
day 14 and 28, and deviated drastically from other individuals. Analyses were 1124 
first run including those individuals and secondly with excluding them as 1125 
outliers. Significance of results did not differ after their removal, so they were 1126 
excluded from the data set for all analyses, leaving 44 individuals. General 1127 
linear mixed effect models (Gaussian family, lme4 package) were used to 1128 
investigate the effect of population of origin and days post inoculation (dpi) on 1129 
antibody concentration (Table S1). Bacterial isolate ID and year of 1130 
M.gallisepticum isolate were controlled for as random effect terms. We then 1131 
tested for interactions between antibody concentrations at specific time points 1132 
between populations using paired t-tests, with a significance level of 0.05.  1133 
 1134 
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To assess if circulating IgY was associated with symptom severity, we 1135 
removed individuals who did not develop symptoms (n=6).  We then used a 1136 
linear regression with mean quantitative conjunctival score as the response 1137 
variable and host IgY concentration at 14, 28 and 35 dpi as the explanatory 1138 
terms.  1139 
Second, we investigated the effect of host IgY concentration on the probability 1140 
of developing clinical symptoms that would be lethal in the wild using a logistic 1141 
regression with mortality as the response term and host IgY concentration at 1142 
14, 28 and 35 dpi as the explanatory terms. Next, the relationship between 1143 
host IgY and pathogen clearance was examined using logistic regression with 1144 
clearance as a response variable and host IgY concentration at 14 and 28 as 1145 
explanatory terms. Clearance was defined using qualitative symptom scoring, 1146 
which was measured until day 34. We therefore excluded antibody 1147 
concentration at 35dpi from our clearance models. Logistic regression was 1148 
also used to test the association between the response term clearance and 1149 
the explanatory terms host IgY concentration at 14 and 28. Measurements of 1150 
symptom score (and therefore host recovery) were taken until 34 dpi, and so 1151 
antibody concentration at 35dpi was excluded from the analyses. For all 1152 
models with a single explanatory term significance was determined by 1153 
comparing the MAM with the null model (which only contained the response 1154 
variable) using ANOVA.  1155 
 1156 
 1157 
 1158 
 1159 
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Results 1160 
Antibody Response  1161 
1. Population differences in concentration of systemic IgY  1162 
 1163 
To identify whether an increased humoral response had accompanied the 1164 
evolution of resistance in coevolved house finch populations, we compared 1165 
systemic IgY concentration between individuals originating from coevolved 1166 
and unexposed populations at 14, 28 and 35 days post inoculation (dpi). 1167 
Alabama birds mounted a higher antibody response over the course of 1168 
infection than Arizona birds (GLM, estimate=0.01, Χ2=8.99, p=<0.01, Table 1169 
S1). However, this population difference was due to differences in antibody 1170 
production at day 14 only (14 dpi: paired t-test, T19= 2.15, P=0.04; 28 dpi: 1171 
paired t-test, T19= -0.83, P= 0.42; 35 dpi: paired t-test, T19= -1.72, P= 0.10).  1172 
 1173 
 1174 
 1175 
 1176 
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 1177 
Figure 1. Systemic antibody (IgY) concentration in finches from 1178 
coevolved, Alabama (blue) and unexposed, Arizona populations (red) at 1179 
14, 28 and 35 dpi. Populations differ significantly in their early IgY responses 1180 
two weeks post inoculation.   1181 
 1182 
 1183 
2. Protective benefits of IgY  1184 
 1185 
Mean symptom severity was not associated with circulating antibody 1186 
concentration at day 14 (R2 =0.01688, t42 = -0.849, P = 0.4005; Y=72.63 -1187 
15.11X), day 28 (R2 =0.0006128, t42 =-0.16, P = 0.8733; Y= 48.744 -1.808X) 1188 
or day 35 (R2 = 0.06568, t42 = 1.718, P = 0.0931; Y= 0.3712 23.3488 X), 1189 
indicating that antibody levels had no significant relationship with infection 1190 
associated damage to host conjunctival tissues. Similarly, we found no 1191 
significant association between antibody concentration at day 14 (logistic 1192 
regression: Z= -1.534, df=42, p=0.1128), 28 (logistic regression: Z= 0.557, 1193 
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df=42, p= 0.5753) or 35 (logistic regression: Z= 1.192, df=42, p= 0.2248) on 1194 
the probability of host death, suggesting that antibody concentration had no 1195 
relationship with the log likelihood of infection induced mortality. Furthermore, 1196 
we found no significant association between IgY levels at days 14 (logistic 1197 
regression: Z= 1.469, df=40, p= 0.1245) or 28 (logistic regression: Z= 0.228, 1198 
df=40, p= 0.8206) and the probability of recovery from symptoms. Finally, 1199 
antibody concentration was not a significant predictor of the probability of 1200 
pathogen clearance (IgY day 14: logistic regression: Z= 0.215, df=42, 1201 
p=0.8305; IgY day 28: logistic regression: Z=  -0.800, df=42, p= 0.4007), 1202 
which indicates that antibody levels had no significant relationship with the 1203 
probability of clearing infection.   1204 
 1205 
Population differences in gene expression 1206 
 1207 
The gene expression profile of birds from the unexposed population (Arizona) 1208 
was characterised by the up-regulation of genes involved with innate immunity 1209 
(Akrin-2 isoform X1, Lysophosphatidylcholine acyltransferase 1 and Sorting 1210 
nexin-3 isoform X1); glucose metabolism via the insulin receptor pathway 1211 
(Insulin receptor substrate 4 and Phosphatidylinositol 4,5-bisphosphate 3-1212 
kinase catalytic subunit alpha isoform); inflammation (Cyclin-dependent 1213 
kinase 19 like); proteolysis (Mast-cell protease 1A-like and Dipeptidyl 1214 
peptidase 2 isoform X3) and response to damage/stress (DNA-polymerase 1215 
kappa isoform X1). However, the gene expression profile of birds originating 1216 
from the coevolved population (Alabama) was characterised by the up-1217 
regulation of genes associated with adaptive immunity (AP-1 complex subunit 1218 
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gamma-1; inflammation (NF-kappa-B-activating protein); angiogenesis 1219 
(Heparanase-isoform X2); autophagy (Myotubularin-related protein 8 and 1220 
Autophagy-related protein 9A) and the mitochondrial electron transport chain 1221 
(Dynamin-1-like protein isoform X4; Calcium uptake protein 2, mitochondrial 1222 
isoform X2 and NADH dehydrogenase [ubiquinone] flavoprotein 3, 1223 
mitochondrial; Table 2, Figure 3).  1224 
 1225 
 1226 
 1227 
Figure 2. Log fold difference in transcript expression. Subset of 1228 
transcripts associated with adaptive immunity (AD; N=1); angiogenesis (N=1); 1229 
autophagy (AU; N2); glucose metabolism (GM; N=2); immunity (I; N=1); 1230 
innate immunity (IN; N=2); inflammation (INF; N=5); mitochondrial electron 1231 
transport chain (M; N=3); proteolysis (P; N=2) and stress/damage (S; N=1). 1232 
Negative values represent higher expression in Arizona birds relative to 1233 
Alabama and positive values represent higher expression in Alabama relative 1234 
to Arizona. Abbreviations were assigned to correspond with grouping by 1235 
function(Table 2).1236 
Table 2. Differentially expressed transcripts between unexposed and coevolved finch populations  
Vertebrate Homologue LFC Abbreviation GO Biological Process Grouping 
AP-1 complex subunit gamma-1 
 
 
Heparanase isoform X2 
 
9.92 
 
 
7.75 
AD1 
 
 
AN1 
Antigen processing and presentation of 
exogenous peptide antigen via MHC class II 
 
Angiogenesis involved in wound healing 
 
Adaptive immune 
response 
 
Angiogenesis 
NF-kappa-B-activating protein 
 
9.61 INF5 T cell differentiation in thymus 
 
Adaptive immune 
response 
Myotubularin-related protein 8 11.22 AU1 Negative regulation of autophagy 
Autophagy 
Autophagy-related protein 9A 4.53 AU2 Autophagosome assembly Autophagy 
Insulin receptor substrate 4 
 
14.83 GM1 Insulin receptor signalling pathway 
 
Glucose metabolism 
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic 
subunit alpha isoform 
 
9.40 GM2 Insulin receptor substrate binding 
 
Glucose metabolism 
Ectonucleotide pyrophosphatase/phosphodiesterase family 
member 3 
 
7.86 I1 Immune response 
 
Immune associated 
Akirin-2 isoform X1 
 
9.83 INF4 Innate immune response 
 
Innate immune 
response 
Lysophosphatidylcholine acyltransferase 1 
 
8.27 IN2 Neutrophil degranulation 
 
Innate immune 
response 
Sorting nexin-3 isoform X1  
 
10.67 IN3 Intralumenal vesicle formation 
 
Innate immune 
response 
Cyclin-dependent kinase19-like 
 
11.69 INF1 Positive regulation of inflammatory response 
 
Inflammation 
Dynamin-1-like protein isoform X4 
 
8.10 M1 Mitochondrion organization Mitochondrial 
Calcium uptake protein 2, mitochondrial isoform X2 
 
10.94 M2 Mitochondrial calcium ion homeostasis 
 
Mitochondrial 
NADH dehydrogenase [ubiquinone] flavoprotein 3, 
mitochondrial 
 
9.19 M3 Mitochondrial ATP synthesis coupled electron 
transport 
 
Mitochondrial 
Mast cell protease 1A-like 
 
10.85 P1 Proteolysis 
 
Proteolysis 
Dipeptidyl peptidase 2 isoform X3 
 
8.94 P2 Proteolysis 
 
Proteolysis 
DNA polymerase kappa isoform X1 
 
Tyrosine-protein kinase Fer-like 
 
E3 UFM1-protein ligase 1 
 
11.62 
 
8.39 
 
9.20 
 
S1 
 
INF2 
 
INF3 
Cellular response to DNA damage stimulus 
 
Actin cytoskeleton reorganization 
 
Negative regulation of apoptotic process 
 
Stress 
 
Immune associated 
 
Immune associated 
A subset (N=19) of the successfully annotated, differentially expressed isoforms (N=103) in Alabama (bold) and Arizona, chosen for their relation to 
immunity; inflammation; mitochondrial electron transport chain; proteolysis; stress; glucose metabolism and angiogenesis. For full details of differentially 
expressed isoforms see Supplementary Table 1. 	
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Discussion 1741	
Many parasites, including M.gallisepticum are capable of manipulating host 1742	
immune responses. This means that assessing which components of host 1743	
immune responses are protective can be complex. Here, we demonstrate that 1744	
finches from coevolved populations show higher systemic IgY concentration 1745	
relative to those from unexposed populations at 2 weeks post infection, but 1746	
that IgY concentration has no clear relationship with host recovery, mortality 1747	
or clearance of M.gallisepticum. Transcriptional profiles of both populations 1748	
revealed stark inter-population differences, with finches originating from 1749	
unexposed populations exhibiting greater expression of transcripts that relate 1750	
to inflammation and innate immune processes relative to those from 1751	
coevolved populations, who overall, showed enhanced adaptive immunity. 1752	
Furthermore, our results suggest that coevolved birds do not benefit from 1753	
protection through increased antibody response, and exhibit the potential to 1754	
avoid immune manipulation by the pathogen.   1755	
 1756	
Our results suggest that antibody concentration is significantly higher in 1757	
finches originating from Alabama at 14 dpi. However, we were unable to find a 1758	
link between IgY concentration and recovery, mortality and pathogen 1759	
clearance. This may be attributable to the fact that we know relatively little 1760	
about the role of IgY in pathogen control. IgY is understood to be the 1761	
functional equivalent of mammalian IgG, which (among its versatile roles) is 1762	
involved in antigen detection, although little is known about its role in 1763	
activating complement pathways (Warr et al., 1995). Previous studies in 1764	
poultry have found no evidence for a protective role of IgY against	1765	
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M.gallisepticum infection (Noormohammadi et al., 2002). However, three 1766 
independent studies of M.gallisepticum infection in chickens have suggested 1767 
a primary role for the local secretory antibody, IgA in controlling 1768 
M.gallisepticum infection through the prevention of bacterial establishment in 1769 
mucosal cells at the site of infection (Yagihashi et al., 1987, 1992; Avakiana & 1770 
Leyb, 1993). However, given the tractability of taking haematological samples 1771 
relative to tracheal washings in live birds, systemic IgY was examined here as 1772 
an effective measure of the level host resistance through investigating its 1773 
efficacy.  1774 
 1775 
One reason for inter-population differences in antibody response may be that 1776 
higher circulating antibody titres arise a result of increased activation of the 1777 
other innate/acquired processes that are effective for protection.  In 1778 
concordance with results from a previous experimental infection of birds from 1779 
the same populations (Bonneaud et al., 2012b),  we found transcriptional 1780 
differences between populations in genes related to both innate and acquired 1781 
immune components. Antibodies are generated by the action of the adaptive 1782 
immune system, and therefore it is entirely plausible that heightened antibody 1783 
concentration may be related to proliferation of B-lymphocytes in response to 1784 
infection. It is also important to note that much of the variation in host immune 1785 
phenotype is likely influenced by pathogen genotype x host genotype 1786 
interactions (Lazzaro & Little, 2009).  Indeed, house finches are continually 1787 
adapting to M.gallisepticum, and therefore it is unlikely that their response to 1788 
infection is optimally adapted at any one point in time.   1789 
 1790 
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One of the key mechanisms for pathogen clearance in vertebrate immunity is 1791 
the inflammatory response (Ashley et al., 2012). Dysregulation of this 1792 
response can be damaging to host tissues (referred to as autoimmunity) or at 1793 
worst, fatal (Warrington et al., 2011; Wiersinga et al., 2014). Recent studies in 1794 
house finches have shown that the pathogenicity of M.gallisepticum involves 1795 
the promotion of pro-inflammatory cytokines at the early stages of infection (3-1796 
6 dpi) (Vinkler et al., 2018). Here we show that genes associated with 1797 
promoting and regulating inflammation were highly expressed in Arizona 1798 
finches. First, cyclin dependent kinase 19-like (INF1) was up regulated in 1799 
finches from Arizona, relative to birds from Alabama.  Cyclin dependent 1800 
kinases (CDKs), are part of the pro-inflammatory response and expression of 1801 
the components of the CDK/cyclin system are regulated by the NFκβ (nuclear 1802 
factor κβ) transcription factors (Schmitz & Kracht, 2016). In addition, three 1803 
other genes: Tyrosine-protein kinase Fer-like (INF2); E3 UFM1-protein ligase 1804 
1 (INF3) and Akirin-2 isoform X1 (INF4) were also more highly expressed in 1805 
Arizona finches relative to Alabama. INF2 acts downstream of EGFR to 1806 
promote activation of NFκβ and cell proliferation (Tsygankov, 2003), INF3 is 1807 
thought to be involved with modulating NFκβ signalling (Li et al., 2017), and 1808 
INF4 is necessary for the expression of a subset of NFκβ genes, as well as 1809 
IL-6 production (Ghosh & Hayden, 2008).  1810 
 1811 
In finches from coevolved populations, we find only one gene with a potential 1812 
link to inflammation: NFκβ activating protein (INF5), which induces pro-1813 
inflammatory NFκβ transcription factors (Baeuerle & Henkel, 1994). Evidence 1814 
of a pro-inflammatory response in coevolved finches is consistent with recent 1815 
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results from Vinkler and colleagues, who demonstrate strong pro-1816 
inflammatory responses in coevolved birds originating from Virginia in 1817 
response to a post-resistance isolate of M.gallisepticum (Vinkler et al., 2018). 1818 
However, as birds originating from unexposed populations appear to show 1819 
heightened expression of a higher number of genes relating to inflammation 1820 
compared with those from coevolved populations, this may be indicative that 1821 
coevolved birds have developed an enhanced ability to decrease their 1822 
inflammatory responses to M.gallisepticum, which could protect individuals 1823 
from immune manipulation by the pathogen.  1824 
 1825 
Along side the potential for avoidance of immune-manipulation, finches from 1826 
Alabama also appear to show enhanced adaptive immunity. Here, we show 1827 
that finches originating from Alabama up-regulate AP-1 complex subunit 1828 
gamma-1, which is associated with antigen presentation via MHC class II 1829 
(Hiltbold & Roche, 2002). The major histocompatibility complex (MHC) is a 1830 
component of the acquired immune response, involved in pathogen 1831 
recognition. The role of MHC molecules is to bind to foreign antigens and 1832 
present them on cell surfaces for recognition by T cells (Janeway et al., 2001). 1833 
In chickens, a shift in infiltrating populations of CD4+ and CD8+ T-cell 1834 
receptors associated with MHC recognition has been recorded in response to 1835 
infection with M.gallisepticum (Gaunson et al., 2000b). In house finches, 1836 
increased expression of MHC invariant chain II, which is essential for the 1837 
assembly of MHC class II molecules, was also found in finches from Alabama, 1838 
with down regulation of this gene in Arizona birds (Bonneaud et al., 2012b), 1839 
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suggesting that the MHC complex may have been subject to selection during 1840 
the evolution of resistance.  1841 
                                                                                            1842 
Mounting a protective immune response is usually accompanied by some 1843 
physiological cost (Boots & Haraguchi, 1999) and it has been known for some 1844 
time that the strength of immune responses are dependent on trade offs with 1845 
other energy-requiring processes, such as reproduction (Webster & 1846 
Woolhouse, 1999).  In a previous study, it was shown that finches originating 1847 
from Alabama lost significantly more mass relative to those from Arizona in 1848 
response to infection, and that these individuals also harbored lower bacterial 1849 
loads, and highly expressed immune-related genes (Bonneaud et al., 2012a), 1850 
suggesting that infection may give rise to different energetic needs in birds 1851 
from coevolved versus unexposed populations.  In our study, finches from 1852 
Alabama up-regulated three genes involved in the mitochondrial electron 1853 
transport chain, and therefore associated with energy expenditure/usage: 1854 
Dynamin-1-like protein isoform X4; Calcium uptake protein 2, mitochondrial 1855 
isoform X2 and NADH dehydrogenase [ubiquinone] flavoprotein 3. Taken 1856 
together, the results of the present study may provide further evidence for a 1857 
distinct cost of immunity to M.gallisepticum, demonstrating that energy 1858 
requirements during infection may differ between populations.  1859 
 1860 
In addition, we were able to find evidence of another inter-population 1861 
difference in energy usage that may relate directly either differential costs of 1862 
infection, or may represent another mechanism of host manipulation by 1863 
M.gallisepticum. Finches from unexposed populations showed significant up-1864 
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regulation of two genes involved in glucose metabolism via the insulin 1865 
transduction pathway: Insulin receptor substrate 4 and Phosphatidylinositol 1866 
4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, as well as a gene 1867 
involved with the stress response: DNA polymerase kappa isoform X1.  The 1868 
insulin transduction pathway is essential for maintaining glucose homeostasis, 1869 
although has many roles including countering inflammation through inhibition 1870 
of NFκβ pathways (Dandona et al., 2001). Studies examining physiological 1871 
stress, have shown that the stress system and the immune system are 1872 
intimately linked (Elenkov et al., 1999), with periods of acute/chronic stress 1873 
either boosting or decreasing the immune response respectively and resulting 1874 
hypercortisolemia  (Dhabhar et al., 2012). Furthermore, as insulin is directly 1875 
opposed by the action of cortisol, infection can sometimes lead to 1876 
hyperglycemia through hyperinsulinemia or in extreme cases, insulin 1877 
resistance (McGuinness, 2005). In the future, an additional comparison with a 1878 
non-inoculated individuals is necessary in order to determine whether 1879 
Alabama birds in fact down-regulate genes involved with insulin pathways 1880 
relative to Arizona birds, in which case, this may purely represent differential 1881 
energy usage between populations. Conversely, our results may demonstrate 1882 
an interaction between stress and the action of the immune system in 1883 
unexposed individuals if these genes are up regulated in Arizona birds only; in 1884 
which case, this may indicate that coevolved populations have evolved a 1885 
mechanism to avoid this damaging effect. 1886 
 1887 
Through examining immune measures in relation to measures of host health, 1888 
as well as using next generation sequencing techniques, we were able to 1889 
uncover the lack of protective benefits of IgY, as well as elucidate some of the 1890 
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other immune components that may confer host survival. A number of 1891 
unexplored avenues remain. For example, a more comprehensive 1892 
understanding of the pathogenesis and virulence factors of M.gallisepticum in 1893 
house finches specifically will enable a more thorough understanding of the 1894 
results presented here. In particular, this would help in partitioning which 1895 
components of the immune system are host and pathogen driven. 1896 
Furthermore, comparisons of responses to infection at additional time points 1897 
during infection (for example in the early stages) and their relationship with 1898 
host fitness are needed to further explore in detail, the adaptive significance of 1899 
immune measures.  1900 
 1901 
 1902 
 1903 
 1904 
 1905 
 1906 
 1907 
 1908 
 1909 
 1910 
 1911 
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Supplementary figures and tables  1912 
 1913 
 1914 
 1915 
Figure S1. Flow diagram of the 2 strain - 2 phenotype SIR model. Model 1916 
illustration showing the flow of movements of individuals in the population 1917 
(!! +  !!) subdivided into (!! =  !!  +  !!! +  !!!  +  !!) and (!! =  !!  +  !!! +1918  !!!  +  !!) where b(t) is the seasonal birth rate, !(!) is the seasonal 1919 
transmission coefficient, σ is the recovery rate, ! is the disease-associated 1920 
mortality rate, and !(!) is the natural and season-dependent death rate. 1921 
  1922 
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 1923 
 1924 
 1925 
 1926 
Figure S2. Seasonal variation in birth, death and disease transmission. 1927 
(a) Seasonal variation in birth rate, !(!, !!, !!), with peaks in mid-summer. (b) 1928 
Seasonal variation in mortality rate, !(!, !!, !!). (c) Semi-annual variation in 1929 
disease transmission rate, !(!,!!, !!). Parameter values as in Table 1 (main 1930 
text). 1931 
 1932 
  1933 
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 1934 
 1935 
Figure S3. Stratified prevalence of M.gallisepticum. Timeseries showing 1936 
infection prevalence in each of the four host classes: !!"!  (black), !!"! (blue), !!!  1937 
(red) and !!! (green). Initially, prevalence is highest in !!"!  (susceptible hosts 1938 
infected with low virulence Mg) because high rates of mortality in susceptible 1939 
birds (initially the most common host genotype) put high virulence strains at a 1940 
disadvantage. However, as the prevalence of the resistant host phenotype 1941 
increases, prevalence of the high virulence bacterial strain increases, as 1942 
carrying the resistance trait reduces the overall fitness costs imposed by the 1943 
bacteria and thus allows for the evolution towards higher levels of virulence. 1944 
Parameter values: !! = 1,!! = 1,!! = 0.1, !! = 2; other parameter values as 1945 
in Table 1 (main text). 1946 
  1947 
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 1948 
 1949 
Figure S4.  The effects of the recovery rate on the selection of host 1950 
resistance and bacterial virulence. (a) Relative prevalence of the resistance 1951 
host phenotype 10 years post emergence. Increasing the rate at which birds 1952 
recover from infection leads to slower selection of resistance due to the 1953 
overall reduction in infection prevalence and hence selection pressure. (b) 1954 
Timeseries showing the relative frequency of the high virulence Mg strain. 1955 
With an increase in the recovery rate and therefore decrease in selection 1956 
pressure, there is a reduction in the rate of host phenotypic change, leading to 1957 
decrease in the rate at which the more virulent bacterial strain becomes 1958 
dominant. Parameter values: (a)  !! = 2; (b) !! = 2,!! = 1,!! = 0.1 ; other 1959 
parameter values as in Table 1 (main text). 1960 
 1961 
 1962 
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 1963 
 1964 
Figure S5: The effect of relative susceptibility on the selection of host 1965 
resistance and bacterial virulence. (a) Following disease emergence, there 1966 
is a significant decrease in the number of susceptible (solid line) and total 1967 
number of hosts (dashed line) in the population over time. (b) Number of 1968 
individuals infected with the low virulence (solid line) and high virulence strain 1969 
(dashed line) over time showing initial dominance of the low virulent strain, 1970 
which eventually gets outcompeted. (c) Change in the proportion of the host 1971 
population with a non-resistant or resistant phenotype (Nnr and Nr, 1972 
respectively). (d) Proportion of host population infected with low or high 1973 
virulence strains over time showing an initial expansion of the low virulence 1974 
strain until the number of resistant hosts has reached a critical threshold that 1975 
tips the balance in favour of the more virulent strain. Parameter values: 1976 !! = 0.18, !! = 1.3; other parameter values as in Table 1 (main text). (e) 1977 
Relative prevalence of the resistance host phenotype 10 years post 1978 
emergence. Decreasing susceptibility results in slower selection of host 1979 
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resistance due to the decrease in overall infection prevalence and selection 1980 
pressure. (f) Relative prevalence of the virulent bacterial strain 10 years post 1981 
emergence. High levels of disease-induced mortality rates will select for 1982 
decreased virulence regardless of susceptibility to infection. Yellow circles 1983 
indicate parameter values used in (a)-(d). 1984 
 1985 
 1986 
Figure S6. The effect of parasite clearance on the selection of host 1987 
resistance and bacterial virulence. (a) Following disease emergence, there 1988 
is a significant decrease in the number of susceptible (solid line) and total 1989 
number of hosts (dashed line) in the population over time. (b) Number of 1990 
individuals infected with the low virulence (solid line) and high virulence strain 1991 
(dashed line) over time showing initial dominance of the low virulent strain, 1992 
which eventually gets outcompeted. (c) Change in the proportion of the host 1993 
population with a non-resistant or resistant phenotype (Nnr and Nr, 1994 
respectively). (d) Proportion of host population infected with low or high 1995 
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virulence strains over time showing an initial expansion of the low virulence 1996 
strain until the number of resistant hosts has reached a critical threshold that 1997 
tips the balance in favour of the more virulent strain. Parameter values: 1998 !! = 3, !! = 1.4; other parameter values as in Table 1 (main text). (e) Relative 1999 
prevalence of the resistance host phenotype 10 years post emergence. 2000 
Increasing the rate at which hosts recover from infection leads to slower 2001 
selection of resistance due to the overall reduction in infection prevalence and 2002 
hence selection pressure. (f) Relative prevalence of the virulent bacterial 2003 
strain 10 years post emergence. Increasing the rate at which hosts recover 2004 
from infection still results in the more virulent pathogen dominating 2005 
transmission after ten years, as infection associated death is not so high that 2006 
the pathogen’s transmission is impeded. Yellow circles indicate parameter 2007 
values used in (a)-(d). 2008 
 2009 
 2010 
Figure S7: RSEM correlation matrix of sample similarity. Stark differences 2011 
are shown in the transcriptional profiles between Alabama and Arizona 2012 
individuals. Similarity decreases by colour scale, with yellow representing 2013 
100% similarity	2014 
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Table S1: Differentially expressed transcripts between Alabama and 1766 
Arizona finches.  1767 
Vertebrate Homologue LFC GO Biological Process Species 
Insulin receptor substrate 4 -14.83 insulin receptor signaling pathway Zonotrichia albicollis 
WD repeat-containing protein 81 isoform X1 -14.23 aggrephagy Serinus canaria 
Probable ATP-dependent RNA helicase 
DDX17 isoform X2 -13.43 androgen receptor signaling pathway Falco peregrinus 
Basic leucine zipper and W2 domain-
containing protein 1 -12.11 regulation of transcription, DNA-templated 
Serinus 
canaria/Taeniopygia 
guttata/Zonotrichia 
albicollis 
Putative spermidine/spermine N1-acetyl 
transferase 1 variant 4 -11.78 angiogenesis Taeniopygia guttata 
Cyclin-dependent kinase 19-like, partial -11.69 positive regulation of inflammatory response Cariama cristata 
DNA polymerase kappa isoform X1 -11.62 cellular response to DNA damage stimulus Serinus canaria 
DNA-binding protein RFX7 isoform X2 -11.61 regulation of transcription from RNA polymerase II promoter Parus major 
Cullin-4B -11.52 cell cycle Apaloderma vittatum 
Muscleblind-like protein 1 isoform X14 -11.48 myoblast differentiation Serinus canaria 
Golgin subfamily B member 1 isoform X1 -11.41 ER to Golgi vesicle-mediated transport Serinus canaria 
WD repeat-containing protein 81 isoform X1 -11.05 aggrephagy Serinus canaria 
Mast cell protease 1A-like -10.85 proteolysis Serinus canaria 
Hypothetical protein AV530_004877 -10.84 unknown 
 Nesprin-3 isoform X4 -10.67 cytoskeletal anchoring at nuclear membrane Serinus canaria 
Sorting nexin-3 isoform X1 -10.67 intralumenal vesicle formation Ficedula albicollis 
Eukaryotic translation initiation factor 5 -10.63 activation of GTPase activity Serinus canaria 
Protein LLP homolog -10.59 dendrite extension Corvus brachyrhynchos 
Muscleblind-like protein 1 -10.48 myoblast differentiation Leptonychotes weddellii 
Nuclear pore complex protein Nup214 
isoform X1 -10.33 intracellular transport of virus Serinus canaria 
F-box only protein 30 -10.22 post-translational protein modification Serinus canaria 
DnaJ homolog subfamily A member 2 -9.95 positive regulation of cell proliferation Zonotrichia albicollis 
Akirin-2 isoform X1 -9.83 innate immune response Falco peregrinus 
Tuberin-like -9.43 unknown Melopsittacus undulatus 
Phosphatidylinositol 4,5-bisphosphate 3-
kinase catalytic subunit alpha isoform -9.39 adaptive immune response Dasypus novemcinctus 
E3 UFM1-protein ligase 1 -9.19 negative regulation of apoptotic process Corvus cornix cornix 
Putative ATP-dependent RNA helicase 
DDX5, partial -9.17 
alternative mRNA splicing, via 
spliceosome Charadrius vociferus 
Hypothetical protein UY3_18385 -9.04 unknown Chelonia mydas 
Cytosolic acyl coenzyme A thioester 
hydrolase -9.04 acyl-CoA metabolic process Fukomys damarensis 
Lysine-specific demethylase 3B, partial -9.02 histone H3-K9 demethylation Serinus canaria 
Dipeptidyl peptidase 2 isoform X3 -8.94 proteolysis Serinus canaria 
Protein FAM172A-like, partial -8.93 unknown Haliaeetus albicilla 
ATP-dependent RNA helicase SUPV3L1, 
mitochondrial -8.93 chromatin maintenance 
Aquila chrysaetos 
canadensis 
Transcriptional adapter 1, partial -8.89 histone H3 acetylation Haliaeetus albicilla 
Mas-related G-protein coupled receptor 
member A1-like -8.89 chemosensory behavior Zonotrichia albicollis 
tRNA selenocysteine 1-associated protein 1-
like isoform X4 -8.81 selenocysteine incorporation Zonotrichia albicollis 
Peptidase M20 domain-containing protein 2, 
partial -8.77 unknown Geospiza fortis 
PHD finger protein 10 isoform X2 -8.70 nervous system development Pseudopodoces humilis 
ATP-dependent RNA helicase DDX42, 
partial -8.68 protein localization Phalacrocorax carbo 
Glycogenin-1 isoform X2 -8.64 unknown Serinus canaria 
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Protein fantom isoform X6 -8.56 brain development Serinus canaria 
Uncharacterized protein LOC108963215 -8.56 unknown Serinus canaria 
Bcl-2-associated transcription factor 1 
isoform X5 -8.46 apoptotic process 
Balearica regulorum 
gibbericeps 
Tyrosine-protein kinase Fer-like -8.38 actin cytoskeleton reorganization Haliaeetus albicilla 
Conserved oligomeric Golgi complex subunit 
1 -8.37 ER to Golgi vesicle-mediated transport Taeniopygia guttata 
Sodium channel protein type 5 subunit 
alpha, partial -8.32 trial cardiac muscle cell action potential Leptosomus discolor 
Lysophosphatidylcholine acyltransferase 1 -8.27 neutrophil degranulation Zonotrichia albicollis 
Protein phosphatase 1M, partial -8.21 unknown Parus major 
Apoptotic protease-activating factor 1 
isoform X2 -8.16 
activation of cysteine-type endopeptidase 
activity involved in apoptotic process Sturnus vulgaris 
Origin recognition complex subunit 3 isoform 
X2 -8.15 DNA replication Serinus canaria 
Bcl-2-associated transcription factor 1 
isoform X3 -8.06 apoptotic process Serinus canaria 
Protein yippee-like 2 -8.01 unknown Alligator mississippiensis 
Ectonucleotide 
pyrophosphatase/phosphodiesterase family 
member 3 
-7.86 immune response 
Serinus canaria 
Fas-activated serine/threonine kinase -7.47 apoptotic signaling pathway Sturnus vulgaris 
ATP-binding cassette sub-family A member 
2 isoform X4 -7.07 unknown Serinus canaria 
Tankyrase-2 isoform X1 -5.57 multicellular organism growth Parus major 
SUN domain-containing ossification factor 
isoform X3 -3.71 multicellular organism development Serinus canaria 
RNA-binding protein 5 13.44 apoptotic process Geospiza fortis 
BAG family molecular chaperone regulator 5 
isoform X1 12.69 Golgi organization Zonotrichia albicollis 
Katanin p60 ATPase-containing subunit A1 
isoform X1 12.68 cell cycle Serinus canaria 
Hypothetical protein UY3_18385 12.35 unknown Chelonia mydas 
AFG3-like protein 2 11.95 axonogenesis Geospiza fortis 
Uncharacterized protein LOC108447830 11.77 unknown Corvus brachyrhynchos 
Eukaryotic translation initiation factor 5 11.29 activation of GTPase activity Serinus canaria 
Myotubularin-related protein 8 11.22 negative regulation of autophagy Serinus canaria 
Receptor tyrosine-protein kinase erbB-3 
precursor 11.06 cranial nerve development  
Nesprin-1 10.97 cytoskeletal anchoring at nuclear membrane Serinus canaria 
Calcium uptake protein 2, mitochondrial 
isoform X2 10.94 mitochondrial calcium ion homeostasis Zonotrichia albicollis 
Eukaryotic translation initiation factor 5 10.78 activation of GTPase activity Serinus canaria 
Coiled-coil domain-containing protein 117 
isoform X2 10.71 unknown Sturnus vulgaris 
Eukaryotic translation initiation factor 5 10.66 activation of GTPase activity Serinus canaria 
Phosphatase and actin regulator 4 isoform 
X5 10.59 actin cytoskeleton organization Serinus canaria 
AP-1 complex subunit gamma-1, partial 9.92 
antigen processing and presentation of 
exogenous peptide antigen via MHC class 
II 
Anas platyrhynchos 
NF-kappa-B-activating protein 9.61 T cell differentiation in thymus Aquila chrysaetos canadensis 
Transmembrane protein C9orf91 homolog 9.59 unknown Geospiza fortis 
Hypothetical protein Y956_04768, partial 9.58 unknown Nipponia nippon 
Centrosomal protein of 290 kDa isoform X7 9.52 cilium assembly Serinus canaria 
UAP56-interacting factor isoform X2 9.48 mRNA export from nucleus Parus major 
UAP56-interacting factor-like isoform X1 9.22 mRNA export from nucleus Zonotrichia albicollis 
NADH dehydrogenase [ubiquinone] 
flavoprotein 3, mitochondrial 9.19 
mitochondrial ATP synthesis coupled 
electron transport Serinus canaria 
Probable ATP-dependent RNA helicase 
DHX40 9.13 mRNA splicing, via spliceosome Serinus canaria 
Phosphatidylinositol transfer protein beta 
isoform isoform X1 9.12 lipid metabolic process Zonotrichia albicollis 
Serine/threonine-protein kinase PAK 3-like 9.09 axonogenesis Serinus canaria 
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 1768 
Table shows transcripts with a significance value (FDR) <0.01, p-value <0.01 1769 
and a log fold change >4 (N=103). The functional annotation of each 1770 
predicted differentially expressed protein-coding sequence was performed 1771 
with a BLAST search against the nonredundant (NR) database on NCBI using 1772 
Blast2GO with an E-value threshold of 1e-3. 1773 
 1774 
 1775 
 1776 
 1777 
 1778 
 1779 
 1780 
 1781 
 1782 
Endoplasmic reticulum lectin 1 9.08 ERAD pathway Serinus canaria 
Protein phosphatase Slingshot homolog 1-
like, partial 9.07 actin cytoskeleton organization Gavia stellata 
Serine/threonine-protein kinase PAK 3-like 8.87 axonogenesis Ficedula albicollis 
Required for meiotic nuclear division protein 
1 homolog isoform X4 8.74 unknown Serinus canaria 
Protein lin-54 homolog isoform X1 8.72 cell cycle Serinus canaria 
Inositol polyphosphate 5-phosphatase 
OCRL-1 isoform X3 8.67 cilium assembly Serinus canaria 
Hypothetical protein N323_08112, partial 8.63 unknown Cathartes aura 
Endoribonuclease Dicer 8.57 apoptotic DNA fragmentation Geospiza fortis 
Nuclear envelope pore membrane protein 
POM 121 8.36 intracellular transport of virus Serinus canaria 
Hypothetical protein N301_07267 8.35 unknown Charadrius vociferus 
T-lymphoma invasion and metastasis-
inducing protein 2 isoform X4 8.34 
G-protein coupled receptor signaling 
pathway Taeniopygia guttata 
Golgin subfamily A member 4 isoform X6 8.32 Golgi to plasma membrane protein transport Serinus canaria 
Dynamin-1-like protein isoform X4 8.09 cellular response to oxygen-glucose deprivation Serinus canaria 
Heparanase isoform X2 7.75 angiogenesis involved in wound healing Serinus canaria 
Ganglioside-induced differentiation-
associated protein 2 isoform X1 7.46 response to retinoic acid Zonotrichia albicollis 
Hypothetical protein N334_14123, partial 6.96 unknown Pelecanus crispus 
CAMP-dependent protein kinase inhibitor 
alpha 6.89 
negative regulation of cAMP-dependent 
protein kinase activity Acanthisitta chloris 
Phosphatidate cytidylyltransferase 2 6.27 CDP-diacylglycerol biosynthetic process Zonotrichia albicollis 
Apoptosis inhibitor 5 isoform 6.03 apoptotic process Pseudopodoces humilis 
Autophagy-related protein 9A 4.53 autophagosome assembly Serinus canaria 
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Chapter 4: Thesis Discussion 1783 
 1784 
 1785 
Through theoretically modeling the dynamical interplay between host 1786 
resistance and pathogen virulence, we have revealed specific host traits that 1787 
likely led to rapid evolution of both antagonists in just a decade. This work 1788 
suggests that host resistance evolved through an imperfect strategy, and 1789 
likely through a specific type of quantitative immunity that reduces host 1790 
mortality through immune action. Indeed, through previous studies examining 1791 
splenic gene expression profiles, we have seen changes in the regulation of 1792 
genes involved with immune action accompanying the evolution of resistance 1793 
(Bonneaud et al., 2011, 2012b). Subsequently, we tested the efficacy of one 1794 
immune mechanism at protecting hosts from morbidity and mortality. We 1795 
found no evidence to suggest that circulating antibodies were associated with 1796 
an increased likelihood of either pathogen clearance, or recovery from 1797 
symptoms. This finding is similar to previous findings in chickens, where a link 1798 
between increased IgY and increased pathogen control was never made 1799 
(Noormohammadi et al., 2002).  1800 
 1801 
In chapter one, we showed that neither a reduction in host susceptibility to M. 1802 
gallisepticum infections, nor an increase in parasite clearance rates, is 1803 
compatible with patterns observed in previous studies (Bonneaud et al., 2011; 1804 
Hawley et al., 2013). In fact, model simulations suggest that the impact of 1805 
each on infection prevalence would reduce disease-induced selection 1806 
pressure to the extent that we would no longer be able to observe shifts in 1807 
resistant and virulent host and pathogen phenotypes. Instead, our results 1808 
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suggest that the rapid, disease-induced selection of host resistance traits 1809 
based on reducing infection-associated mortality, for instance through a 1810 
lowering of pathogen load, was the key driver for the subsequent increase in 1811 
bacterial virulence. 1812 
 1813 
Comparing transcriptional responses of coevolved versus naïve house finches 1814 
to infection provided novel insights into the nature of effective immune 1815 
mechanisms in this system. Interestingly, finches from Arizona up-regulated 1816 
many genes involved in inflammation, where as those from Alabama showed 1817 
minimal evidence of an increased inflammatory response. Taken together with 1818 
the fact that M.gallisepticum is known to potentiate inflammatory responses in 1819 
chickens (Ganapathy & Bradbury, 2003), this is indicative that one 1820 
mechanism for effective protection from M.gallisepticum infection may be to 1821 
avoid its immune-manipulation capabilities. This may be effective through 1822 
limiting the ability of the pathogen to create more microlesions, therefore 1823 
infiltrating epithelial and endothelial tissues. Although this warrants more 1824 
investigation, this could provide precursory evidence through which finches 1825 
can limit mortality.  1826 
 1827 
Based on evidence presented here regarding an as yet unknown role of 1828 
insulin pathways and differential energy usage between populations in 1829 
response to infection, many unexplored avenues remain. Arizona finches 1830 
exhibited up-regulation of a gene associated with stress, in line with similar 1831 
previous findings (Bonneaud et al., 2011). Insulin is directly opposed by the 1832 
action of cortisol, and therefore infection can sometimes lead to 1833 
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hyperglycemia through hyperinsulinemia or in extreme cases, insulin 1834 
resistance (McGuinness, 2005). Future comparison with a non-inoculated 1835 
individuals will help determine whether Alabama birds in fact down-regulate 1836 
genes involved with insulin pathways relative to Arizona birds, in which case, 1837 
this may purely represent differential energy usage between populations. 1838 
Conversely, our results may demonstrate an interaction between stress and 1839 
the action of the immune system in unexposed individuals if these genes are 1840 
up regulated in Arizona birds only; in which case, this may indicate that 1841 
coevolved populations have evolved a mechanism to avoid this damaging 1842 
effect. 1843 
 1844 
In light of knowledge gained here regarding the evolution of host immune 1845 
responses, it would now be useful to understand how corresponding pathogen 1846 
traits that confer increased virulence have co-evolved during the same time 1847 
frame. Further study into how these findings relate to host and pathogen 1848 
fitness will also allow us to investigate potential patterns of local adaptations 1849 
in this system. Moreover, as we were able to identify specific genes that are 1850 
up regulated in response to infection, future studies may specifically test the 1851 
efficacy of such response pathways in conferring protection, as we have done 1852 
with IgY.  1853 
 1854 
In conclusion, the results presented in this thesis are relevant for other host-1855 
pathogen systems, particularly as a demonstration of the power of host-driven 1856 
processes influencing the evolutionary trajectory of host resistance and 1857 
pathogen virulence. We know from previous modeling studies that the specific 1858 
host trait under selection is hypothesized to have serious implications for 1859 
	 75	
whether pathogens evolve increasing or decreasing virulence in response 1860 
(Gandon & Michalakis, 2000; Restif & Koella, 2003). Furthermore, we know 1861 
from serial passage experiments that imperfect immunity can result in 1862 
increases to pathogen virulence (Mackinnon & Read, 2004). Our study 1863 
emphasizes the need to understand directional evolutionary responses when 1864 
making decisions about control studies or eradication efforts, because if the 1865 
strategy is imperfect, increases in pathogen virulence may undermine any 1866 
effort. In addition, we present a rare example of the use of RNA-seq based 1867 
transcriptomics to characterize the host transcriptome in response to infection. 1868 
RNA-seq based transcriptomics has scarcely been applied to wild systems, 1869 
largely due to the inability to control conditions in wild populations and due to 1870 
the potential for environmental contamination. To the best of our knowledge, 1871 
the use of transcriptomics for comparisons of unexposed and coevolved host 1872 
responses has not yet been done in this system.  Finally, and as has been 1873 
noted elsewhere (Pedersen & Babayan, 2011), immune components are not 1874 
always protective under all circumstances, which was demonstrated in 1875 
chapter 3. Therefore, when measuring immune responses, future studies 1876 
should assess whether they are beneficial in the face of the specific pathogen 1877 
of interest as this is likely to affect host evolutionary trajectories.  1878 
 1879 
 1880 
 1881 
 1882 
 1883 
 1884 
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